Effects of obesity on lower urinary tract symptoms in Korean BPH patients

Asian Journal of Andrology

Volumn 11, Issue 6, 2009, Pages 663-668

  Lee, Seung Hwan ^a   Kim, Joon Chul ^b   Lee, Ji Youl ^b   Kim, Jang Hwan ^a   Oh, Cheol Young ^c   Lee, Seung Wook ^d   Yoo, Se Jeong ^a   Chung, Byung Ha ^a  

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Hallym University   (South Korea)

^d Eulji University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; KOREA; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PROSTATE; PROSTATE HYPERTROPHY; SCORING SYSTEM; URINARY URGENCY; WAIST CIRCUMFERENCE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; HUMANS; KOREA; MALE; OBESITY; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; WAIST CIRCUMFERENCE;

EID: 71049165916     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2009.62     Document Type: Article

References (25)

1. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate 1989; 2: 33-50.
2. Nandeesha H. Benign prostatic hyperplasia: Dietary and metabolic risk factors. Int Urol Nephrol 2008; 40: 649-56.
3. Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 2002; 75: 685-97.
4. Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994; 140: 989-1002.
5. Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, et al. A prospective study of plasma hormone levels, nonhormonal factors and development of benign prostatic hyperplasia. Prostate 1995; 26: 40-9.
6. Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998; 1: 157-62.
7. Kim DM, Ahn CW, Nam SY. Prevalence of obesity in Korea. Obes Rev 2005; 6: 117-21.
8. Park YH, Chung MK. The prevalence of clinical benign prostatic hyperplasia and lower urinary tract symptoms in South-East Korea: A community-based study. J Pusan Natl Univ Hosp 2001; 9: 141-57.
9. Lee MW, Lee KS. The prevalence of benign prostatic hyperplasia in self-referral populations over aged 50. Korean J Urol 1996; 37: 263-7.
10. World Health Organization. Western Pacific Region. International Association for the Study of Obesity. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney, Australia: Health Communications Australia Pty Limited; 2000.
11. Xie LP, Bai Y, Zhang XZ, Zheng XY, Yao KS, et al. Obesity and benign prostatic enlargement: A large observational study in China. Urology 2007; 69: 680-4.
12. Sarma AV, Jaffe CA, Schottenfeld D, Dunn R, Montie JE, et al. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: Clinical correlates of prostate volume among black men. Urology 2002; 59: 362-7.
13. Signorello LB, Tzonou A, Lagiou P, Samoli E, Zavitsanos X, et al. The epidemiology of benign prostatic hyperplasia: A study in Greece. BJU Int 1999; 84: 286-91.
14. Dahle SE, Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002; 168: 599-604.
15. Kim YD, Yang WJ, Song YS, Park YH. Correlation between prostate volume and metabolic or anthropometric factors in male visitors to a health promotion center. Korean J Urol 2008; 49: 139-44.
16. Lee SY, Min HG, Choi SH, Kim YJ, Oh SW, et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity 2006; 14: 172-9.
17. Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli Labate AM, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991; 40: 101-4.
18. Barqawi AB, Golden BK, O'Donnell C, Brawer MK, Crawford ED. Observed effect of age and body mass index on total and complexed PSA: Analysis from a national screening program. Urology 2005; 65: 708-12.
19. Gat Y, Gornish M, Heiblum M, Joshua S. Reversal of benign prostate hyperplasia by selective occlusion of impaired venous drainage in the male reproductive system: Novel mechanism, new treatment. Andrologia 2008; 40: 273-81.
20. Ku JH, Kim ME, Lee NK, Park YH, Ahn JO. Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 2003; 61: 132-6.
21. Kristal AR, Chi C, Tangen CM, Goodman PJ, Etzioni R, et al. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 2006; 106: 320-8.
22. Ochiai A, Fritsche HA, Babaian RJ. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Urology 2005; 66: 819-23.
23. Burke JP, Jacobson DJ, McGree ME, Roberts RO, Girman CJ, et al. Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota. Urology 2006; 67: 22-5.
24. Shiri R, Hakama M, Hakkinen J, Auvinen A, Huhtala H, et al. The effects of lifestyle factors on the incidence of nocutria. J Urol 2008; 180: 2059-62.
25. Yoshimura K, Terada N, Matsui Y, Terai A, Kinukawa N, et al. Prevalence of and risk factors for nocturia: Analysis of a health screening program. Int J Urol 2004; 11: 282-7.